デフォルト表紙
市場調査レポート
商品コード
1308792

有効性試験市場:試験タイプ別、用途別-2023-2030年の世界予測

Efficacy Testing Market by Test Type, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
有効性試験市場:試験タイプ別、用途別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

有効性試験の世界市場は大きく成長し、2023年には3億670万米ドル、CAGRは6.80%と予測され、2030年には4億8,676万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の有効性試験市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.有効性試験の世界市場規模および予測は?

2.予測期間中、世界の有効性試験市場を形成するCOVID-19の阻害要因と影響は?

3.有効性試験の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.有効性試験の世界市場における競争戦略は?

5.有効性試験の世界市場における技術動向と規制の枠組みは?

6.有効性試験の世界市場における主要ベンダーの市場シェアは?

7.有効性試験の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 製品の汚染管理に重点を置いています
      • 製薬分野の研究開発活動への投資の増加
      • さまざまな医療機器における抗菌有効性試験の用途の拡大
    • 抑制要因
      • さまざまな有効性試験とトライアルにかかるコストが高い
    • 機会
      • 主に製薬および医療分野における新製品の安全性と安定性に対する政府の政策と取り組み
      • 高度な有効性試験の継続的な開発
    • 課題
      • 有効性試験の承認には複雑で時間のかかるプロセス
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 有効性試験市場テストタイプ別

  • 抗菌・防腐剤有効性試験
    • 迅速な試験方法
    • 従来の試験方法
  • 消毒剤有効性試験
    • 表面試験方法
    • サスペンション試験方法

第7章 有効性試験市場:用途別

  • 消費者製品
  • 化粧品およびパーソナルケア製品
  • 医療機器
  • 医薬品製造

第8章 南北アメリカの有効性試験市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の有効性試験市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの有効性試験市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. EFFICACY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. EFFICACY TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. EFFICACY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2022 VS 2030 (%)
  • FIGURE 5. EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. EFFICACY TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. EFFICACY TESTING MARKET DYNAMICS
  • FIGURE 8. EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES EFFICACY TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. EFFICACY TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. EFFICACY TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. EFFICACY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. EFFICACY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 6. EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. EFFICACY TESTING MARKET SIZE, BY RAPID TEST METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. EFFICACY TESTING MARKET SIZE, BY TRADITIONAL TEST METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 10. EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. EFFICACY TESTING MARKET SIZE, BY SURFACE TEST METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. EFFICACY TESTING MARKET SIZE, BY SUSPENSION TEST METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. EFFICACY TESTING MARKET SIZE, BY CONSUMER PRODUCT , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. EFFICACY TESTING MARKET SIZE, BY COSMETICS & PERSONAL CARE PRODUCT , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. EFFICACY TESTING MARKET SIZE, BY MEDICAL DEVICE , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. EFFICACY TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES EFFICACY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. VIETNAM EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. DENMARK EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EGYPT EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. FINLAND EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FRANCE EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. GERMANY EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. ISRAEL EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ITALY EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NIGERIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NORWAY EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. POLAND EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. QATAR EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. RUSSIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SPAIN EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SWEDEN EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWITZERLAND EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. TURKEY EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY DISINFECTANT EFFICACY TESTING, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM EFFICACY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. EFFICACY TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 187. EFFICACY TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 188. EFFICACY TESTING MARKET LICENSE & PRICING
目次
Product Code: MRR-4F4C362635CB

The Global Efficacy Testing Market is forecasted to grow significantly, with a projected USD 306.70 million in 2023 at a CAGR of 6.80% and expected to reach a staggering USD 486.76 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Efficacy Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Efficacy Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Test Type, market is studied across Antimicrobial/Preservative Efficacy Testing and Disinfectant Efficacy Testing. The Antimicrobial/Preservative Efficacy Testing is further studied across Rapid Test Method and Traditional Test Method. The Disinfectant Efficacy Testing is further studied across Surface Test Method and Suspension Test Method. The Disinfectant Efficacy Testing is projected to witness significant market share during forecast period.

Based on Application, market is studied across Consumer Product, Cosmetics & Personal Care Product, Medical Device, and Pharmaceutical Manufacturing. The Consumer Product is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Efficacy Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Efficacy Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Efficacy Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Efficacy Testing Market?

4. What is the competitive strategic window for opportunities in the Global Efficacy Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Efficacy Testing Market?

6. What is the market share of the leading vendors in the Global Efficacy Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Efficacy Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Efficacy Testing Market, by Test Type, 2022 vs 2030
  • 4.3. Efficacy Testing Market, by Application, 2022 vs 2030
  • 4.4. Efficacy Testing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High focus on contamination control in products
      • 5.1.1.2. Increasing investments for the research and development activities in the pharmaceutical sector
      • 5.1.1.3. Growing applications of antimicrobial efficacy testing in various medical devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost involved in different efficacy testing and trials
    • 5.1.3. Opportunities
      • 5.1.3.1. Government policies and efforts towards new product safety and stability mainly in the pharma and medical sector
      • 5.1.3.2. Ongoing development of advanced efficacy testing
    • 5.1.4. Challenges
      • 5.1.4.1. Complex and time-consuming process for approval for efficacy testing
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Efficacy Testing Market, by Test Type

  • 6.1. Introduction
  • 6.2. Antimicrobial/Preservative Efficacy Testing
    • 6.2.1. Rapid Test Method
    • 6.2.2. Traditional Test Method
  • 6.3. Disinfectant Efficacy Testing
    • 6.3.1. Surface Test Method
    • 6.3.2. Suspension Test Method

7. Efficacy Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Consumer Product
  • 7.3. Cosmetics & Personal Care Product
  • 7.4. Medical Device
  • 7.5. Pharmaceutical Manufacturing

8. Americas Efficacy Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Efficacy Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Efficacy Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing